IL-23p40 specific immunoglobulin derived proteins,...

Chemistry: analytical and immunological testing – Peptide – protein or amino acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S069100

Reexamination Certificate

active

07807471

ABSTRACT:
An anti-IL-23 specific human Ig derived protein, isolated nucleic acids that encode at least one anti-IL-23 Ig derived protein, vectors, host cells, transgenic animals or plants, and methods of making and using thereof are useful as therapeutic and diagnostic compositions, methods and devices. The anti-IL-23 Ig derived protein preferably binds to one or more of the Seg 1, Seg 2, and Seg 3 epitopes of the p40 subunit of IL-23.

REFERENCES:
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 6060284 (2000-05-01), Bazan
patent: 6479634 (2002-11-01), Bazan
patent: 6495667 (2002-12-01), Bazan
patent: 6610285 (2003-08-01), Hirata
patent: 6756481 (2004-06-01), Chirica et al.
patent: 6800460 (2004-10-01), Oppmann et al.
patent: 6835825 (2004-12-01), Bazan
patent: 2003/0162261 (2003-08-01), Oppmann et al.
patent: 2004/0223969 (2004-11-01), Oft et al.
patent: 2004/0258686 (2004-12-01), Chirica et al.
patent: 2005/0244874 (2005-11-01), Kastelein et al.
patent: WO 99/05280 (1999-02-01), None
patent: WO 99/40195 (1999-08-01), None
patent: WO 00/09552 (2000-02-01), None
patent: WO 00/53631 (2000-09-01), None
patent: WO 00/70049 (2000-11-01), None
patent: WO 01/18051 (2001-03-01), None
patent: WO 01/85790 (2001-11-01), None
patent: WO 2004/042009 (2004-05-01), None
patent: WO 2004/058178 (2004-07-01), None
patent: WO 2004/071517 (2004-08-01), None
patent: WO 2004/081190 (2004-09-01), None
Peter J. Barnes, “Cytokine-directed therapies for the treatment of chronic airway diseases,” Cytokine & Growth Factor Reviews 14 (2003): 511-522 (2003).
Trinchieri, et al., “The IL-12 Family of Heterodimeric Cytokines: New Players in the Regulation of T Cell Responses,” Immunity, 19: 641-644 (2003).
Maguire van Seventer, et al., “Interferon-β differentially regulates expression of the IL-12 family members p35, p40, p19 and EB13 in activated human dendritic cells,” Journal of Neuroimmunology, 133: 60-71 (2002).
Yadav, et al., “Cytokines and autoimmunity: redundancy defines their complex nature,” Current Opinion in Immunology, 15: 697-703 (2003).
Murphy, et al., “Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation,” Journal of Experimental Medicine, 198(12): 1951-1957 (2003).
David M. Frucht, “IL-23: A Cytokine That Acts on Memory T Cells,” Science STKE, 114: 1-3 (2002).
Wiekowski, et al., “Ubiquitous Transgenic Expression of the IL-23 Subunit p19 Induces Multiorgan Inflammation, Runting, Infertility, and Premature Death,” Journal of Immunology, 166: 7563-7570 (2001).
Belladonna, et al., “IL-23 and IL-12 Have Overlapping, but Distinct, Effects on Murine Dendritic Cells,” The Journal of Immunology, 168: 5448-5454 (2002).
Parham, et al., “A Receptor for the Heterodimeric Cytokine IL-23 is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R,” The Journal of Immunology, 168: 5699-5708 (2002).
Oppmann, et al., “Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12,” Immunity, 13: 715-725 (2000).
Cua, et al., “Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain,” Nature, 421: 744-748 (2003).
D'Andrea, et al., “Production of Natural Killer Cell Stimulatory Factor (Interleukin 12) by Peripheral Blood Mononuclear Cells,” Journal of Experimental Medicine, 176: 1387-1398 (1992).
GenBank Accession No. AF301620, Oppmann, et al., Dec. 4, 2000.
GenBank Accession No. AA418955, Hillier, et al., May 12, 1997.
GenBank Accession No. C06368, J. Takeda, Aug. 9, 1996.
GenBank Accession No. AA418747, Hillier, et al., May 12, 1997.
PCT International Search Report dated Oct. 26, 2006.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

IL-23p40 specific immunoglobulin derived proteins,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with IL-23p40 specific immunoglobulin derived proteins,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and IL-23p40 specific immunoglobulin derived proteins,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4151283

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.